Form SC14D9C - Written communication relating to third party tender offer
29 Maio 2024 - 10:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
Akili, Inc.
(Name of Subject Company)
Akili, Inc.
(Name of Person(s) Filing Statement)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
00974B107
(CUSIP Number of Common Stock)
Matthew Franklin
President and Chief Financial Officer
Akili, Inc.
71 Commercial Street, Mailbox 312,
Boston, MA 02109
(617) 456-0597
(Name, address, and telephone number of person authorized to receive notices and communications
on behalf of the persons filing statement)
With a copy to:
Joshua Zachariah, Esq.
Sarah Ashfaq, Esq.
Tevia Pollard, Esq.
Goodwin Procter LLP
100 Northern Ave
Boston, MA 02210
(617) 570-1000
|
☒
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
The information set forth under Items 1.01 and 9.01 of the Current Report on Form 8-K filed by Akili, Inc. on May 29, 2024 (including all exhibits attached
thereto and incorporated therein by reference) is incorporated herein by reference.
Akili (NASDAQ:AKLI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Akili (NASDAQ:AKLI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
